Navigation Links
American Society for Microbiology's newest journal earns a high impact factor in latest rankings
Date:7/9/2012

Less than two years after publishing its first issue, the online open-access journal mBio is now ranked among the top 20 highest-impact microbiology journals according to Thomson Reuters, which has just released its Journal Citation Reports for 2011. Thomson Reuters tracks the number of times scholarly articles are cited by other authors and compiles the information into "impact factors", rough measures of the quality or standing of a journal within its field. Since the American Society for Microbiology (ASM) launched mBio in April 2010, it already boasts an impact factor of 5.311 and ranks 16th among all microbiology-centered journals.

mBio is ASM's first broad-scope open-access journal and is published solely online. Among the journal's other distinguishing features is its streamlined decision policy, a response to what many in science perceive to be overly onerous revision requirements by many study reviewers. Using a rigorous peer-review process with an eye to importance and impact, mBio offers authors an up or down decision on manuscripts and will request only minor revisions. The average time to first decision for all mBio manuscripts (excluding those editorially rejected) is 23 days.

In its short history, mBio has published a number of studies and opinion pieces that have garnered national and international attention, in such media outlets as the New York Times, MSNBC, and CNN. An article published in February 2011 by scientists at Northwestern University was the first to reveal the presence of human DNA in a bacterium, the pathogen Neisseria gonorrhoeae, a genetic entanglement that many thought was not possible and contributes to our understanding of how pathogens and hosts can evolve together. The news about gonorrhea was picked up by bloggers and writers for the national press.

mBio published another high-profile article in February 2012 which revealed that one type of MRSA, a bacterium that causes invasive skin infections, most likely acquired its resistance to antibiotics while it lived in livestock. The findings illustrated the best evidence to date linking antibiotic use on the farm and antibiotic resistance in an organism that can cause lethal infections in humans. The article added fuel to an already fiery debate about the wisdom and ethics of using antibiotics as growth promoters in livestock.

Editor-in-Chief, Arturo Casadevall, says that the goal for the next year is a continued focus on identifying highly important papers.

While the journal rankings by Thomson Reuters are not the final word on journal quality, they do offer authors guidance on which journals are more likely to garner attention from other scientists in their particular field. ASM expects that mBio's streamlined editorial process, rigorous review process, and high caliber research studies will continue to provide readers with a quality publication and will propel the journal even further up the impact factor rankings in 2012.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. Looking for the next American hyrax?
2. Investigation of American Oriental Bioengineering, Inc. by Securities Lawyers at Goldfarb LLP Law Firm for Potential Shareholder Claim
3. 5th Latin American Conference on Lung Cancer
4. American Association for the Advancement of Science - Pacific Division convenes in Boise June 24-27
5. Tips from the Journals of the American Society for Microbiology
6. Top young Latin-American scientists named Pew Biomedical Fellows
7. UMass Medical School scientist named 2012 Pew Latin-American Fellow in the Biomedical Sciences
8. CU-Boulder-led team finds microbes in extreme environment on South American volcanoes
9. The American Society for Microbiology honors Anthony R. Richardson
10. The American Society for Microbiology honors Susan Sharp
11. The American Society for Microbiology honors Geoffrey L. Smith
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... RATON, Florida , March 31, 2016 ... LEGX ) ("LegacyXChange" or the "Company") ... for potential users of its soon to be launched ... video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide ... the use of DNA technology to an industry that ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. Stock-Callers.com has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
Breaking Biology Technology: